161 related articles for article (PubMed ID: 37166199)
21. Immune Responses to a Recombinant Glycoprotein E Herpes Zoster Vaccine in Adults Aged 50 Years or Older.
Cunningham AL; Heineman TC; Lal H; Godeaux O; Chlibek R; Hwang SJ; McElhaney JE; Vesikari T; Andrews C; Choi WS; Esen M; Ikematsu H; Choma MK; Pauksens K; Ravault S; Salaun B; Schwarz TF; Smetana J; Abeele CV; Van den Steen P; Vastiau I; Weckx LY; Levin MJ;
J Infect Dis; 2018 May; 217(11):1750-1760. PubMed ID: 29529222
[TBL] [Abstract][Full Text] [Related]
22. Safety of the adjuvanted recombinant zoster vaccine in adults aged 50 years or older. A phase IIIB, non-randomized, multinational, open-label study in previous ZOE-50 and ZOE-70 placebo recipients.
Ocran-Appiah J; Boutry C; Hervé C; Soni J; Schuind A;
Vaccine; 2021 Jan; 39(1):6-10. PubMed ID: 33277059
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of the adjuvanted recombinant zoster vaccine (RZV) by sex, geographic region, and geographic ancestry/ethnicity: A post-hoc analysis of the ZOE-50 and ZOE-70 randomized trials.
Willer DO; Oostvogels L; Cunningham AL; Gervais P; Gorfinkel I; Hyung Kim J; Talarico C; Wascotte V; Zahaf T; Colindres R; Schuind A;
Vaccine; 2019 Oct; 37(43):6262-6267. PubMed ID: 31537443
[TBL] [Abstract][Full Text] [Related]
24. Cost and utility in immunocompromised subjects who developed herpes zoster during the randomized V212 inactivated varicella-zoster vaccine (ZV
Eriksson J; Hunger M; Bourhis F; Thorén R; Popmihajlov Z; Finelli L; Jiang Y
Expert Rev Pharmacoecon Outcomes Res; 2020 Dec; 20(6):613-621. PubMed ID: 31721601
[No Abstract] [Full Text] [Related]
25. Varicella-zoster virus-specific enzyme-linked immunospot assay responses and zoster-associated pain in herpes zoster subjects.
Tyring SK; Stek JE; Smith JG; Xu J; Pagnoni M; Chan IS; Silber JL; Parrino J; Levin MJ
Clin Vaccine Immunol; 2012 Sep; 19(9):1411-5. PubMed ID: 22787198
[TBL] [Abstract][Full Text] [Related]
26. Vaccine profile of herpes zoster (HZ/su) subunit vaccine.
Cunningham AL; Heineman T
Expert Rev Vaccines; 2017 Jul; 16(7):1-10. PubMed ID: 28486850
[TBL] [Abstract][Full Text] [Related]
27. The impact of varicella zoster virus: chronic pain.
Opstelten W; McElhaney J; Weinberger B; Oaklander AL; Johnson RW
J Clin Virol; 2010 May; 48 Suppl 1():S8-13. PubMed ID: 20510265
[TBL] [Abstract][Full Text] [Related]
28. The impact of herpes zoster and post-herpetic neuralgia on quality-of-life.
Johnson RW; Bouhassira D; Kassianos G; Leplège A; Schmader KE; Weinke T
BMC Med; 2010 Jun; 8():37. PubMed ID: 20565946
[TBL] [Abstract][Full Text] [Related]
29. Effect of Recombinant Zoster Vaccine on Incidence of Herpes Zoster After Autologous Stem Cell Transplantation: A Randomized Clinical Trial.
Bastidas A; de la Serna J; El Idrissi M; Oostvogels L; Quittet P; López-Jiménez J; Vural F; Pohlreich D; Zuckerman T; Issa NC; Gaidano G; Lee JJ; Abhyankar S; Solano C; Perez de Oteyza J; Satlin MJ; Schwartz S; Campins M; Rocci A; Vallejo Llamas C; Lee DG; Tan SM; Johnston AM; Grigg A; Boeckh MJ; Campora L; Lopez-Fauqued M; Heineman TC; Stadtmauer EA; Sullivan KM;
JAMA; 2019 Jul; 322(2):123-133. PubMed ID: 31287523
[TBL] [Abstract][Full Text] [Related]
30. Public health impact of recombinant zoster vaccine for prevention of herpes zoster in US adults immunocompromised due to cancer.
Curran D; Patterson BJ; Carrico J; Salem A; La EM; Lorenc S; Hicks KA; Poston S; Carpenter CF
Hum Vaccin Immunother; 2023 Dec; 19(1):2167907. PubMed ID: 36880669
[TBL] [Abstract][Full Text] [Related]
31. The herpes zoster subunit vaccine.
Cunningham AL
Expert Opin Biol Ther; 2016; 16(2):265-71. PubMed ID: 26865048
[TBL] [Abstract][Full Text] [Related]
32. Burden of post-herpetic neuralgia in a sample of UK residents aged 50 years or older: findings from the Zoster Quality of Life (ZQOL) study.
Serpell M; Gater A; Carroll S; Abetz-Webb L; Mannan A; Johnson R
Health Qual Life Outcomes; 2014 Jun; 12():92. PubMed ID: 24920439
[TBL] [Abstract][Full Text] [Related]
33. Impact of Reactogenicity After Two Doses of Recombinant Zoster Vaccine Upon Physical Functioning and Quality of Life: An Open Phase III Trial in Older Adults.
Schmader KE; Levin MJ; Chen M; Matthews S; Riley ME; Woo W; Hervé C; Grupping K; Schuind AE; Oostvogels L; Curran D
J Gerontol A Biol Sci Med Sci; 2021 Feb; 76(3):485-490. PubMed ID: 32530462
[TBL] [Abstract][Full Text] [Related]
34. Vaccines for preventing herpes zoster in older adults.
Gagliardi AM; Andriolo BN; Torloni MR; Soares BG; de Oliveira Gomes J; Andriolo RB; Canteiro Cruz E
Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31696946
[TBL] [Abstract][Full Text] [Related]
35. Herpes zoster infection in the post-hematopoietic stem cell transplant pediatric population may be preceded by transaminitis: an institutional experience.
Berman JN; Wang M; Berry W; Neuberg DS; Guinan EC
Bone Marrow Transplant; 2006 Jan; 37(1):73-80. PubMed ID: 16247423
[TBL] [Abstract][Full Text] [Related]
36. Impact of herpes zoster and post-herpetic neuralgia on health-related quality of life in Miyun District of Beijing, China: An EQ-5D survey.
Zhao D; Suo L; Lu L; Pan J; Peng X; Wang Y; Pang X
Vaccine X; 2023 Dec; 15():100415. PubMed ID: 38124774
[TBL] [Abstract][Full Text] [Related]
37. High incidence of herpes zoster in nonmyeloablative hematopoietic stem cell transplantation.
Su SH; Martel-Laferrière V; Labbé AC; Snydman DR; Kent D; Laverdière M; Béliveau C; Logvinenko T; Cohen S; Lachance S; Kiss T; Roy J
Biol Blood Marrow Transplant; 2011 Jul; 17(7):1012-7. PubMed ID: 20977944
[TBL] [Abstract][Full Text] [Related]
38. Burden of illness, quality of life, and healthcare utilization among patients with herpes zoster in South Korea: a prospective clinical-epidemiological study.
Song H; Lee J; Lee M; Choi WS; Choi JH; Lee MS; Hashemi M; Rampakakis E; Kawai K; White R; Acosta C; Sampalis JS; Cheong HJ
Int J Infect Dis; 2014 Mar; 20():23-30. PubMed ID: 24412314
[TBL] [Abstract][Full Text] [Related]
39. Recombinant Zoster Vaccine (Shingrix
Syed YY
Drugs Aging; 2018 Dec; 35(12):1031-1040. PubMed ID: 30370455
[TBL] [Abstract][Full Text] [Related]
40. Herpes zoster and postherpetic neuralgia.
Johnson RW
Expert Rev Vaccines; 2010 Mar; 9(3 Suppl):21-6. PubMed ID: 20192714
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
